POLYGIENE GROUP AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.58 SEK | +5.04% |
|
+20.35% | +14.73% |
| Apr. 25 | Polygiene Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 15 | Polygiene Group AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 182.6 | 785.8 | 1,772 | 298.4 | 305 | 349.9 | - | - |
| Enterprise Value (EV) 1 | 178.9 | 782.9 | 1,722 | 251.9 | 264.7 | 315.9 | 311.9 | 297.9 |
| P/E ratio | -35.6 x | -479 x | 27.4 x | 14.1 x | -1 x | -87.1 x | 53.2 x | 25.2 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 2.65 x | 9.36 x | 9.76 x | 1.72 x | 2.69 x | 2.73 x | 2.44 x | 2.21 x |
| EV / Revenue | 2.6 x | 9.33 x | 9.48 x | 1.45 x | 2.33 x | 2.46 x | 2.17 x | 1.88 x |
| EV / EBITDA | -33.3 x | 1,117 x | 37.2 x | 12.4 x | -21.7 x | 105 x | 26 x | 16.6 x |
| EV / FCF | 30.5 x | -696 x | 50.4 x | -4.97 x | 444 x | -67.2 x | 57.8 x | 24 x |
| FCF Yield | 3.28% | -0.14% | 1.98% | -20.1% | 0.23% | -1.49% | 1.73% | 4.16% |
| Price to Book | 5.3 x | 28.6 x | 3.41 x | 0.5 x | 1.05 x | 1.22 x | 1.2 x | 1.15 x |
| Nbr of stocks (in thousands) | 20,516 | 20,516 | 35,550 | 36,527 | 36,527 | 36,527 | - | - |
| Reference price 2 | 8.900 | 38.30 | 49.85 | 8.170 | 8.350 | 9.580 | 9.580 | 9.580 |
| Announcement Date | 2/27/20 | 2/25/21 | 2/24/22 | 2/16/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 68.8 | 83.93 | 181.6 | 173.6 | 113.5 | 128.3 | 143.7 | 158.1 |
| EBITDA 1 | -5.379 | 0.701 | 46.29 | 20.34 | -12.2 | 3 | 12 | 18 |
| EBIT 1 | -6.571 | -1.051 | 43.16 | 15.99 | -312.6 | -3.8 | 6.4 | 13.5 |
| Operating Margin | -9.55% | -1.25% | 23.76% | 9.21% | -275.31% | -2.96% | 4.45% | 8.54% |
| Earnings before Tax (EBT) 1 | -6.623 | -1.086 | 40.47 | 15.96 | -313.1 | -3.9 | 6.3 | 13.4 |
| Net income 1 | -5.171 | -1.736 | 64.18 | 21.84 | -303.6 | -4.1 | 6.6 | 14.1 |
| Net margin | -7.52% | -2.07% | 35.34% | 12.58% | -267.42% | -3.2% | 4.59% | 8.92% |
| EPS 2 | -0.2500 | -0.0800 | 1.820 | 0.5800 | -8.310 | -0.1100 | 0.1800 | 0.3800 |
| Free Cash Flow 1 | 5.866 | -1.125 | 34.15 | -50.64 | 0.596 | -4.7 | 5.4 | 12.4 |
| FCF margin | 8.53% | -1.34% | 18.81% | -29.18% | 0.52% | -3.66% | 3.76% | 7.84% |
| FCF Conversion (EBITDA) | - | - | 73.78% | - | - | - | 45% | 68.89% |
| FCF Conversion (Net income) | - | - | 53.21% | - | - | - | 81.82% | 87.94% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/27/20 | 2/25/21 | 2/24/22 | 2/16/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
|---|---|---|---|---|---|
| Net sales 1 | 40.18 | 45.11 | 47.47 | 40.98 | 40 |
| EBITDA | 6.991 | 9.323 | 9.619 | 5.118 | - |
| EBIT | 6.153 | 3.796 | 11.54 | 7.049 | - |
| Operating Margin | 15.31% | 8.41% | 24.32% | 17.2% | - |
| Earnings before Tax (EBT) 1 | 4.123 | 3.783 | 11.53 | 7.046 | -6.384 |
| Net income 1 | 39.03 | 7.121 | 17.18 | 5.724 | -5.131 |
| Net margin | 97.15% | 15.79% | 36.19% | 13.97% | -12.83% |
| EPS | 1.100 | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 2/24/22 | 4/28/22 | 7/28/22 | 10/27/22 | 2/16/23 |
1SEK in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 3.74 | 2.81 | 50.2 | 46.6 | 40.3 | 34 | 38 | 52 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 5.87 | -1.13 | 34.2 | -50.6 | 0.6 | -4.7 | 5.4 | 12.4 |
| ROE (net income / shareholders' equity) | -13.6% | -6.12% | 11% | 3.93% | -68.7% | -1.4% | 2.3% | 4.7% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 1.680 | 1.340 | 14.60 | 16.20 | 7.970 | 7.870 | 8.010 | 8.350 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 1.98 | 4.04 | 3.45 | 49.1 | 3.19 | 4.9 | 4.3 | 4.7 |
| Capex / Sales | 2.88% | 4.82% | 1.9% | 28.3% | 2.81% | 3.82% | 2.99% | 2.97% |
| Announcement Date | 2/27/20 | 2/25/21 | 2/24/22 | 2/16/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +14.73% | 31.92M | |
| +11.47% | 63.22B | |
| -3.47% | 46.34B | |
| +13.72% | 39.97B | |
| +17.83% | 25.46B | |
| +7.27% | 18.68B | |
| -0.57% | 17.24B | |
| -21.73% | 15.81B | |
| +0.22% | 14.9B | |
| -19.10% | 13.74B |
- Stock Market
- Equities
- POLYG Stock
- Financials Polygiene Group AB
